ARCHIVES

Surprise Finding On HRT Stops Large Trial, Women Advised To Reconsider Long-Term Use Due to Increased Breast Cancer Risk

This article is from The Cancer Letter archive.

Vol. 28 No. 28 | July 12, 2002

Download PDF Visit The Full Archive

Related Articles

Regulatory Agencies: FDA Regulation Of Tobacco Signed by President Clinton

September 6, 1996

PFS Is A Benefit “In The Right Context,” Pazdur Says In Q&A On Avastin Approval.

February 29, 2008

Seven New Initiatives For NIH Common Fund

February 26, 2010

Phase III Trial of ThermoDox Fails to Meet Primary Endpoint

February 22, 2013

NCCS Networker Volume 10 Issue 3, Winter 1996

January 13, 1996

FDA Approves Lymphoseek For Imaging Lymph Nodes

March 29, 2013